期刊文献+

手术对肿瘤转移的影响以及麻醉对策 被引量:9

Effect of surgery on cancer recurrence and anaesthetic strategy
原文传递
导出
摘要 背景手术会增加肿瘤的转移,影响肿瘤患者的长期预后。目的通过探讨手术影响肿瘤转移的机制来指导麻醉方法和药物的选择,从而减少肿瘤术后转移的机会。内容介绍了肿瘤转移的过程,以自然杀伤细胞(naturalkillercell,NK)和T辅助(Thelper,Th)细胞为例阐述了肿瘤与免疫的关系,分析了手术增加肿瘤转移的原因,着重讨论了围术期免疫功能抑制的影响因素,包括神经内分泌,炎症,垂体-下丘脑一。肾上腺轴,低体温和输血等5个主要方面。麻醉可以通过β受体阻滞药,环氧酶(cyclo—oxygemase,COX)抑制剂,良好的镇痛,区域麻醉,谨慎选择吸入和静脉麻醉药以及保温和节约用血来减少手术对肿瘤转移的影响。趋向麻醉方法与药物的选择能减少肿瘤术后的转移复发,但仍需大量的前瞻性研究证实。 Background Surgery increases cancer recurrence, which has a negative effect on long-term prognosis. Objective The paper discussed the mechanism of surgery on cancer recurrence to guide the choice of anesthesia method and drugs in order to decrease postoperative cancer recurrence. Content Introduce the process of cancer recurrence, take natural killer cell (NK) and T helper(Th) cells for example to recite the relationship of cancer and immunity. Analyze the reason that surgery increases cancer recurrence, especially the effects on perioperative immune inhibition, including neuroendocrine, inflammation, HPA axis, hypothennia and blood transfusion. β-receptor blocker, cyclo-oxyge-nase (COX) inhibitor, good analgesia, regional anesthesia, careful selection of inhalation as well as intravenous anesthetics, avoidable hypothermia and unnecessary blood transfusion can reduce the surgery effect on cancer recurrence. Trend Good choice of anesthesia method and drugs may decrease postoperative recurrence of cancer. But plenty of prospective studies are required.
作者 周获 缪长虹
出处 《国际麻醉学与复苏杂志》 CAS 2013年第9期808-811,815,共5页 International Journal of Anesthesiology and Resuscitation
关键词 NK细胞 T辅助细胞 肿瘤术后转移复发 麻醉 Natural killer cell T helper cell Post-operative cancer recurrence Anesthesia
  • 相关文献

参考文献24

  • 1Fink T, Ebbesen P, Koppelhusy U. Natural killer cell-mediated basal and interferon -enhanced cytotoxicity against liver cancer cells is significantly impaired under in vivo oxygen conditions. Scand J Immunol, 2003, 58(6): 607-612.
  • 2康培良,黄文,王继德.胰腺癌患者围手术期T细胞亚群和NK细胞活性的动态观察[J].中国肿瘤临床与康复,2005,12(2):103-105. 被引量:7
  • 3Conishi T , Ohishi Y, Imagawa K, et al. An assessment of the immunological environment based on intratumoral cytokine production in renal cell arcinoma. BJU Int, 1999, 83 (4): 488-492.
  • 4Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic efector Th 17 and regulatory T cells. Nature, 2006, 441 (7090): 235 -238.
  • 5Sakaguchi S, Ono M, Setoguchi R, et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self -tolerance and autoimmune disease, Immunol Rev, 2006, 212 (1 ): 8 -27.
  • 6Hiura T, Kagamu H, Miura S, et al. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression. J Immunol, 2005, 175 (8): 5058- 5066.
  • 7Ohira M, Ohdan H, Mitsuta H, et al. Adoptive transfer of TRAIL?expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy. Transplantation, 2006, 82 (12): 1712.
  • 8Wada H, Seki S, Takahashi T, et al. Combined spinal and general anesthesia attenuates liver metastasis by preserving Th1/Th2 Cytokine Balance.Anesthesiology,2007,106(3):499-506.
  • 9Landen CN Jr , Lin YG, Armaiz Pena GN, et al. Neuroendocrine modulation of signal transducer and activator of transcription -3 in ovarian cancer. Cancer Res, 2007, 67(21): 10389-10396.
  • 10Goldfarb Y, Ben -Eliyahu S. Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches. Breast Dis, 2006, 26(2): 99-114.

二级参考文献7

  • 1Kelly JM,Darcy PK,Markby JL,et al.Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection[J].Nat Immunol,2002,3(1):83-90.
  • 2Goto S,Sato M,Kaneko R,et al.Analysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients[J].Cancer Immunol Immunother,1999,48(8):435-442.
  • 3Kjaergaard J,Hokland ME,Agger R,et al.Biodistribution and tumor localization of lymphokine-activated killer T cells following different routes of administration into tumor-bearing animals[J].Cancer Immunol Immunother,2000,48(10):550-560.
  • 4Metelitsa LS,Naidenko OV,Kant A,et al. Human NK T cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells[J].J Immunol,2001,167(6):3114-3122.
  • 5Codfrey DI,Hammond KJ,Poulton LD,et al.NKT cells: facts,functions and fallacies[J].Immunol Today,2000,21(11):573-583.
  • 6刘景田,党小军,章文斌.恶性肿瘤患者外周血中IL-2、IL-2R的表达以及CD_3、CD_4、CD_8、NK细胞活性的变化观察[J].中国现代医学杂志,2001,11(5):30-31. 被引量:23
  • 7刘长安,孙武,邵玉霞,李卓,贾廷珍.大肠癌患者外周血T细胞亚群和NK细胞活性检测的临床意义[J].实用癌症杂志,2001,16(5):476-478. 被引量:48

共引文献6

同被引文献53

  • 1Yoshito Tomimaru,Hiroshi Wada,Shigeru Marubashi,Shogo Kobayashi,Hidetoshi Eguchi,Yutaka Takeda,Masahiro Tanemura,Takehiro Noda,Koji Umeshita,Yuichiro Doki,Masaki Mori,Hiroak Nagano.Fresh frozen plasma transfusion does not affect outcomes following hepatic resection for hepatocellular carcinoma[J].World Journal of Gastroenterology,2010,16(44):5603-5610. 被引量:5
  • 2闻国春.新型肌肉松弛药—罗库溴铵研究进展[J].河北医药,2007,29(7):742-743. 被引量:3
  • 3Papa A,Wan L,Bonora M,et al. Cancer -associated PTENmutants act in a dominant -negative manner to suppress PTENprotein funetion[J]. Cell, 2014, 157(3 ) : 595-610.
  • 4Carnero A. The PKB/AKT pathway in cancer[J]. Curr Pharm Des,2010, 16(1): 3444.
  • 5Staal SP. Molecular cloning of the akt oncogene and its humanhomologues AKT1 and AKT2: amplification of AKT1 in a primaryhuman gastric adenocarcinoma [J]. Proc Natl Acad Sci USA,1987, 84(14): 5034-5037.
  • 6Wang X,Lin Y, Lan F, et al. A GG allele of 3^-side AKT1 SNP isassociated with decreased AKT1 activation and better prognosis ofgastric canoer[J]. J Cancer Res Clin Oncol, 2014, 140(8): 1399-1411.
  • 7Kim EK, Yun SJ, Ha JM,et al. Selective activation of Aktl bymammalian target of rapamycin complex 2 regulates cancer cellmigration, invasion, and metastasis[J]. Oncogene, 2011, 30(26):2954-2963.
  • 8Wang Q, Fan SY, Qian J, et al. AKT2 expression in histopathologicgrading and recurrence of meningiomas [J]. Eur J Surg Oncol,2014,40(9): 1056-1061.
  • 9Fohlin H, Perez-Tenorio G,Fornander T,et al. Akt2 expressionis associated with good long-term prognosis in oestrogen receptorpositive breast cancer[J]. Eur J Cancer, 2013, 49(6) : 1196-1204.
  • 10Grabinski N, Mollmann K, Milde-Langosch K, et al. AKT3 regulatesErbB2, ErbB3 and estrogen receptor alpha expression and contributesto endocrine therapy resistance of ErbB2+ breast tumor cells fromBalb-neuT mice[J]. Cell Signal, 2014,26(5): 1021-1029.

引证文献9

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部